Discovery Of EPHX2 As A Causal Inflammatory Drug Target For Alzheimer’s Disease Using AI/ML And Gene Editing Approaches

Abstract or Session

Poster presentation

July 12, 2026

Lead Author

Program Number/Abstract ID

0249

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.